<?xml version="1.0" encoding="UTF-8"?>
<p id="par0130">Disulfiram (
 <bold>47</bold>, 
 <xref rid="fig0040" ref-type="fig">Fig. 8</xref> ) is an FDA drug and has been used in alcohol aversion therapy. This drug was reported to inhibit the activity of methyltransferase 
 <xref rid="bib0465" ref-type="bibr">[93]</xref>, kinase 
 <xref rid="bib0470" ref-type="bibr">[94]</xref>, and urease 
 <xref rid="bib0470" ref-type="bibr">[94]</xref>, all by reacting with cysteine residues, suggesting broad-spectrum characteristics 
 <xref rid="bib0475" ref-type="bibr">[95]</xref>. Notably, disulfiram (
 <bold>47</bold>) has been reported as an allosteric inhibitor of MERS-CoV PL
 <sup>pro</sup>
 <xref rid="bib0475" ref-type="bibr">[95]</xref>. It was suggested that the administration of 
 <bold>41</bold> together with compound 
 <bold>44</bold> and/or 
 <bold>45</bold>, could synergistically inhibit MERS-CoV papain-like protease 
 <xref rid="bib0475" ref-type="bibr">[95]</xref>.
</p>
